Every year The Scientist identifies the latest and best technologies and techniques in the life-science industry. Nanolive is proud to have been selected for our newest microscope – the CX-A – the world’s first walk-away solution for label-free, long-term live cell imaging. Please follow the link to visit our CX-A product page: https://www.nanolive.ch/products/3d-microscopes/cx-a/.
Editor-in-Chief Bob Grant from The Scientist states: “In 2019, not only do we highlight products that build on established methods as the year’s Top 10 Innovations, we celebrate unique contributions that break new conceptual ground in life science.”
If you wish to be contacted by our team to get a quote or to organize a demo at your institution, just follow this link: https://www.nanolive.ch/enquire-now/.
Congratulations to all winners!
Click on this link https://www.the-scientist.com/features/2019-top-10-innovations-66738 to learn everything about the Top 10 winners!
Read our latest news
12 new scientific publications featuring Nanolive live cell data solutions
We have 11 new publications featuring Nanolive imaging to round-up the end of 2022, and one to welcome 2023! Find links to all twelve papers on topics from mitochondria, to neutrophils, leukemia, red blood cells, and bacteria below.We really saw an increase in groups...
A new diagnostic role for Nanolive’s refractive index imaging?
The refractive index of cellular structures is an intrinsic property that is used by Nanolive’s imaging and digital assays to analyse cells and organelles label-free. The authors of a newly published paper in Cells have innovatively applied this technology to monitor...
Upcoming Webinar – The LIVE Cell Death Assay: Drug discovery applications of cell health, stress, death, and recovery analyses
Showcasing our AI-powered digital cytotoxicity and cell viability assay, we will explore how Nanolive's high-content live cell imaging can be used to increase confidence in lead candidate selection.We will explore the following drug discovery applications of...
